Immuron

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum.

CEO

Steven Lydeamore

CEOSteven Lydeamore

Employees

—

Employees—

Headquarters

Blackburn North, Victoria (VIC)

HeadquartersBlackburn North, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRN Key Statistics

Market cap

11.28M

Market cap11.28M

Price-Earnings ratio

-2.22

Price-Earnings ratio-2.22

Dividend yield

—

Dividend yield—

Average volume

63.32K

Average volume63.32K

High today

$1.94

High today$1.94

Low today

$1.84

Low today$1.84

Open price

$1.93

Open price$1.93

Volume

69.45K

Volume69.45K

52 Week high

$2.87

52 Week high$2.87

52 Week low

$1.50

52 Week low$1.50

Immuron

Why Robinhood?

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. Show more

IMRN Key Statistics

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum.